Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John N Gordon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|April 10, 2009
Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximabAntonio Di Sabatino, Ulpu Saarialho-Kere, Mark G Buckley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cellsUte Gunther, Judith A Holloway, John N Gordon, et al.
Gastroenterology|July 17, 2007
Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodiesAntonio Di Sabatino, Sylvia L F Pender, Claire L Jackson, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
Gastroenterology|October 9, 2007
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac diseaseAntonio Di Sabatino, Karen M Pickard, John N Gordon, et al.
The Lancet. Gastroenterology & Hepatology|September 6, 2016
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trialJohn G Williams, M Fasih Alam, Laith Alrubaiy, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|April 10, 2009
Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximabAntonio Di Sabatino, Ulpu Saarialho-Kere, Mark G Buckley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cellsUte Gunther, Judith A Holloway, John N Gordon, et al.
Gastroenterology|July 17, 2007
Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodiesAntonio Di Sabatino, Sylvia L F Pender, Claire L Jackson, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
Gastroenterology|October 9, 2007
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac diseaseAntonio Di Sabatino, Karen M Pickard, John N Gordon, et al.
The Lancet. Gastroenterology & Hepatology|September 6, 2016
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trialJohn G Williams, M Fasih Alam, Laith Alrubaiy, et al.
The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.
Pageof 2